TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 2 | 8 | 7 | -1 | 21 | 69 | 18 |
| S | %wins | 50 | 0 | 50 | 50 | 0 | 0 | 25 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/10/12 07:54 | 12/10/12 | OSIR | Osiris Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Friedli Peter | MD | DTH | Chairman | S | -476 | 9.52 | 1 | -50 | 0 | 14,223 | I | 31 | 95 | 52 | 2 | 2 | 10 | -1 | -2 | -1 | 5 | -5 | 6 | 12 | 50 |
11/16/12 06:54 | 11/15/12 | OSIR | Osiris Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Friedli Peter | MD | DTH | Chairman | S | -6 | 9.34 | 1 | -1 | 0 | 14,273 | I | 6 | 73 | 56 | -5 | -26 | -11 | -21 | -9 | 5 | 10 | 19 | -7 | 30 | 88 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |